INHIBRX BIOSCIENCES INC (INBX) Stock Analyst Ratings
USA - NASDAQ:INBX - US45720N1037 - Common Stock
57.29 USD
+28.93 (+102.01%)
56.1 USD
-1.19 (-2.08%)
ChartMill assigns a Buy % Consensus number of 43% to INBX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.24. This target is -78.64% below the current price.
INBX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about INBX.
In the previous month the buy percentage consensus was at a similar level.
INBX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-22 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-05-15 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-03-18 | Citizens Capital Markets | Reiterate | Market Perform -> Market Perform |
| 2025-01-22 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2024-07-23 | JMP Securities | Initiate | Market Perform |
| 2024-01-23 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2023-11-20 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-23 | JMP Securities | Maintains | Outperform -> Outperform |
| 2023-05-10 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-08 | JMP Securities | Maintains | Market Outperform |
| 2023-03-07 | Credit Suisse | Reiterate | Outperform |
| 2022-11-08 | Credit Suisse | Maintains | Outperform |
| 2022-10-05 | Evercore ISI Group | Maintains | Outperform |
| 2022-08-09 | Credit Suisse | Maintains | Outperform |
| 2022-03-02 | JMP Securities | Maintains | Market Outperform |
| 2021-11-10 | Credit Suisse | Maintains | Outperform |
| 2021-11-02 | JMP Securities | Maintains | Market Outperform |
| 2021-09-21 | JMP Securities | Initiate | Market Outperform |
INHIBRX BIOSCIENCES INC / INBX FAQ
Can you provide the average price target for INHIBRX BIOSCIENCES INC stock?
6 analysts have analysed INBX and the average price target is 12.24 USD. This implies a price decrease of -78.64% is expected in the next year compared to the current price of 57.29.
What is the consensus rating for INHIBRX BIOSCIENCES INC (INBX) stock?
The consensus rating for INHIBRX BIOSCIENCES INC (INBX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.